Immunity:肠道微生物关键毒素促进炎症反应

2015-04-24 MedSci 生物谷

众所周知,我们的肠道内部寄生着大量的微生物群,这些微生物中有相当一部分对人体是有益的。比如细菌分泌的维生素以及短链脂肪酸能够促进肠道免疫系统的发育。同时,宿主也进化出一些手段来避免不正常的肠道炎症反应。比如肠道上皮覆盖的粘膜层以及抗菌肽能够有效阻止微生物与宿主细胞的过分接触。目前的一些研究发现化学物质诱导的小鼠肠炎症状在肠道微生物缺失的情况下会得到缓解。进一步的研究发现特定的微生物种群能够促进肠道

众所周知,我们的肠道内部寄生着大量的微生物群,这些微生物中有相当一部分对人体是有益的。比如细菌分泌的维生素以及短链脂肪酸能够促进肠道免疫系统的发育。同时,宿主也进化出一些手段来避免不正常的肠道炎症反应。比如肠道上皮覆盖的粘膜层以及抗菌肽能够有效阻止微生物与宿主细胞的过分接触。

目前的一些研究发现化学物质诱导的小鼠肠炎症状在肠道微生物缺失的情况下会得到缓解。进一步的研究发现特定的微生物种群能够促进肠道的炎症反应,例如肠杆菌科的一些菌种。然而,确切的信号通路目前还不清楚。
 
炎症反应的第一步是信号的感应。常见的如病原体侵染或细胞损伤引起的信号能够被宿主的信号识别受体所识别。其中炎症小体是重要的一员(具体关于炎症小体的知识不再赘述)。迄今为止,有一系列炎症小体被鉴定得到,而作为其中最有名的一类炎症小体:NLRP3,能够被不同的配体激活,比如细菌穿孔素,细菌RNA,ATP,晶体物质等。NLRP3在肠道炎症反应中的作用近年来进行了许多深入的研究,然而结果却十分不统一。有的研究发现缺失了NLRP3后小鼠对肠炎更加敏感,然而另外一些研究却得出了相反的结论。关于IL-1b的作用的研究也是十分混乱。
 
最近,来自美国密歇根大学Gabriel Núñez研究组发现了一类特定的肠道微生物P. mirabilis
 
能够促进肠道NLRP3的激活以及IL-1b的分泌,而这一效应是由CCR2+的单核细胞介导的。相关研究结果发表在最近一期的immunity杂志上。
 
首先,作者分别利用SPF小鼠与GF小鼠的粪便对骨髓巨噬细胞进行体外刺激,结果显示:SPF小鼠的粪便能够引起明显的IL-1b的分泌,而GF小鼠的粪便则没有这一效应。之后,作者分别对SPF小鼠以及GF小鼠(或经过抗生素处理的小鼠)进行DSS诱导肠炎的实验。结果显示:DSS诱导之后SPF小鼠肠道固有层细胞会有明显的IL-1b,IL-6以及TNF-a的释放,而微生物缺失后的小鼠体内固有层细胞则以上因子的分泌明显减少。这一结果说明肠道的微生物促进了小鼠肠道附近的炎症反应。
 
之后,作者利用DSS诱导的肠炎模型比较了野生型小鼠与IL-1b-/-小鼠的症状。结果显示:突变体小鼠的肠炎严重程度明显低于野生型。这一实验说明IL-1b是炎症反应的关键分子。接下来,作者利用SPF小鼠的粪便体外刺激野生型,caspase1以及caspase1&11突变体小鼠的骨髓巨噬细胞,通过检测炎性因子的分泌,作者发现IL-1b的释放依赖于caspase1而非caspase11,而TNF-a的释放与两类caspase都没有关系。进一步,作者通过对一系列的突变小鼠骨髓巨噬细胞的检测,发现IL-1b的释放依赖于NLRP3蛋白,同样,体内的实验也证明了这一结论。
 
肠道存在大量的不同类型的免疫细胞,为了寻找哪一类免疫细胞介导了这一炎症反应,作者首先分离DSS刺激后的小鼠肠道固有层(LP)的免疫细胞进行分析,结果显示LP细胞在经过DSS刺激后发生了明显的IL-1b的上升,而IL-6的表达没有差异。之后,作者通过时序性分析发现DSS刺激后IL1b的分泌量与LP中Ly6C+的单核细胞的数量存在明显的相关性。通过进一步的细胞分选与分析,作者发现LP细胞分泌IL-1b的量与其表达Ly6C的量存在明显的相关性。在Ly6chigh的这一细胞亚群中,IL-1b的分泌也受到NLRP3的影响。另外,体内的实验也验证了上述结果(SPF小鼠在DSS刺激后单核细胞分泌IL-1b的量明显多于GF小鼠),并且发现这一类细胞分泌IL-1b的水平同时受到一类趋化因子CCR2的影响。以上实验说明CCR2+ Ly6Chigh的单核细胞是IL-1b的主要贡献来源。
 
随后,作者希望了解哪一类细菌能够引起宿主IL-1B的释放,通过一系列的筛选实验,作者发现在众多能够引起IL-1B释放的细菌中,P. mirabilis的效应最快最强烈。而且这一效应也受到NLRP3等一系列炎症小体蛋白的影响。之后,作者通过单菌定植的实验证明了P. mirabilis在体内的促炎症作用。在此基础上,作者通过基因组水平的分析找到了可能引起宿主免疫反应的一系列基因,并构建了相应的菌株突变体。体内外检测结果显示,只有HpmA蛋白的突变能够完全抑制该细菌对小鼠IL-1b的释放,然而当人为补充hpmA时这一抑制现象得到了解除。以上实验说明hpmA是可能的单核细胞IL-1b信号通路的配体物质。

原始出处:

Sang-Uk Seo, Nobuhiko Kamada, Raúl Muñoz-Planillo, Yun-Gi Kim, Donghyun Kim, Yukiko Koizumi, Mizuho Hasegawa, Stephanie D. Himpsl, Hilary P. Browne, Trevor D. Lawley, Harry L.T. Mobley, Naohiro Inohara, Gabriel Núñez. Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. Immunity, April 21, 2015, 42(4):744-755.DOI:http://dx.doi.org/10.1016/j.immuni.2015.03.004

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
    2015-05-07 acount

    学习过

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
    2015-04-30 dwtouxx

    有用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
    2015-04-26 sumer

    NLRP很火啊!!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
    2015-04-25 cspcsp

    有用

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2030296, encodeId=0c3c203029661, content=<a href='/topic/show?id=25079e7287' target=_blank style='color:#2F92EE;'>#Immunity#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9772, encryptionId=25079e7287, topicName=Immunity)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/C4Qhy5XHSe503Qbjzc1UtDR83BCv66o6P2XRedX9ohsNGa3uEVicFFk2qkuX5zBSmpicepFySBrwoYknhqMdKmtw/132, createdBy=1aca2500179, createdName=12498d2fm51(暂无昵称), createdTime=Tue Jun 30 23:19:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1824596, encodeId=c3c3182459699, content=<a href='/topic/show?id=702a5065860' target=_blank style='color:#2F92EE;'>#微生物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50658, encryptionId=702a5065860, topicName=微生物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b7c20, createdName=wjcjjian, createdTime=Mon Jun 15 10:19:00 CST 2015, time=2015-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22874, encodeId=3959228e4f7, content=学习过, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f0f106091, createdName=acount, createdTime=Thu May 07 18:53:00 CST 2015, time=2015-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22310, encodeId=07512231040, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Thu Apr 30 10:56:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=22069, encodeId=71bd22069cd, content=NLRP很火啊!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c061611816, createdName=sumer, createdTime=Sun Apr 26 20:51:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320811, encodeId=7ecc1320811ac, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Apr 26 01:19:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21939, encodeId=79f4219392b, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21940, encodeId=f1232194031, content=也许吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cspcsp, createdTime=Sat Apr 25 12:28:00 CST 2015, time=2015-04-25, status=1, ipAttribution=)]
    2015-04-25 cspcsp

    也许吧

    0

相关资讯

Cell:肠道微生物影响体重

根据伦敦大学国王学院和康奈尔大学一项研究证实:我们的基因构成通过影响哪种类型的微生物蓬勃发展,决定我们是胖还是瘦。通过研究,研究人员确定了某些特定的,鲜为人知的细菌家族是高度遗传的,此现象在体重低的人中更常见。当这种微生物移植到小鼠中,能防止体重增加。研究结果发表在Cell杂志上,为基于个人的基因组成优化个性化益生菌疗法,以减少与肥胖有关疾病风险铺平道路。以往的研究已经将遗传变异和肠道微生物组成与

微生物研究有助神经变性疾病疗法开发

数万亿的微生物栖息在人类的机体中,这些微生物群体被称之为微生物组,据估计这些微生物群体重2-6磅,其总体重是平均大脑体重的2倍,大部分的微生物生活在机体肠道中,其可以帮助机体消化食物,合成维生素以及抵御感染;但截止到现在研究者对微生物组的研究显示,微生物群体对机体的影响远远超过了肠道,其还会对人类大脑产生影响。 在过去10年里,有研究就表明肠道微生物组合一系列复杂的行为直接相关,比如情绪、情感、

Nature:皮肤微生物可引发特异性免疫应答

项新的研究证实:小鼠皮肤中的免疫系统应对天然定殖于皮肤中的各种微生物(称为共生体)会开发出不同的反应。 国家过敏和传染病研究所(NIAID)为首的科学小组发现,每种类型的微生物会引发独特的不同的免疫系统,这表明皮肤中的免疫细胞能迅速感测和响应微生物群落的变化。 这些发现有助于澄清皮肤共生体(微生物)的保护作用,并可能有助于解释不同皮肤部位的微生物变化如何在皮肤疾病中发挥作用。 皮肤上含有

微生物版的圣诞节,很神奇!

圣诞节了,在这寒冷的冬天里面,微生物也可以用来画出美丽的圣诞树呢,小小的菌落,竟然可以勾勒出如此绚丽多彩的图片。 用真菌形成的圣诞树 边缘和球:费希新萨托菌(Neosartorya fischeri) 帽子:马尔尼菲青霉菌(Penicillium marneffei) Ho,Ho,Ho:黄曲霉(Aspergillus flavus)  拍摄者:Steph

Curr Opin Psychiatry:肠道菌群在抑郁症中扮演重要角色

在全球范围内,抑郁症是导致患者社会功能损害的主要因素,因此进一步探索抑郁症的预防及治疗的新方法具有重要意义。最近大量研究发现,菌群-肠道-大脑轴与情感、行为密切相关,同时,研究还发现,不健康的饮食是抑郁症发生的一个重要危险因素。很多研究发现肠道菌群在抑郁症发生中起着非常重要的作用,是调节饮食和抑郁的桥梁。Curr Opin Psychiatry杂志近日有学者系统回顾了肠道菌群与抑郁及饮食摄入之间的

Science:4000万年,病原体进化竞争从未停止

发表在国际著名杂志Science上的一篇研究论文中,来自犹他大学的研究者通过检测21种灵长类动物的DNA,其中包括从松鼠猴到人类等21种灵长类动物,以此揭示了灵长类抵御感染性细菌的进化历程,该研究同时也阐明了营养性免疫作为宿主防御系统策略的重要性和关键作用。 研究者Matthew Barber表示,我们知道营养性免疫已经40年了,本文研究为我们揭示了过去4000万年以来灵长类动物的进化以及细